Research and Markets (http://www.researchandmarkets.com/research/2gzmns/u_s_market_for)
has announced the addition of the "U.S.
Market for Diabetes Monitoring, Treatment and Drug Delivery 2014"
report to their offering.
According to the Center for Disease Control and Prevention (CDC),
diabetes is the seventh leading cause of death among Americans as of
2014. Moreover, diagnosed diabetes had an estimated cost of over $245
billion in the U.S. in 2013. The prevalence of the disease led to a
market size for diabetes monitoring, treatment and drug delivery of over
$16.7 billion. This market will grow in conjunction with the number of
diagnosed diabetics. Some segments will grow faster than others as the
demand for moder and more efficient products is increasing faster than
the rate of new diabetics. Conversely, reimbursement cuts and declining
prices in some segments will affect the market negatively.
Scope of report: This report pertains to a forecast period of 10 years
(2010 - 2020) for the U.S. Market.
Key Topics Covered:
TABLE of CONTENTS
U.S. DIABETES DIAGNOSIS, TREATMENT AND DRUG DELIVERY market
TRADITIONAL BLOOD GLUCOSE METER MARKET
LANCET AND LANCING DEVICE MARKET
CONTINUOUS GLUCOSE MONITORING MARKET
INSULIN PUMP MARKET
MODERN INSULIN MARKET
INSULIN SYRINGE MARKET
MODERN INSULIN PEN MARKET
For more information visit http://www.researchandmarkets.com/research/2gzmns/u_s_market_for
[ Back To NFVZone's Homepage ]